Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell L... (and obtaining theapprovals required to m...)

Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer

Date:9/5/2007

and obtaining the approvals required to make picoplatin available to this severely underserved patient population."

About Fast Track Designation

The fast track programs of the FDA are designed to facilitate the development and expedite the review of drugs and biologics that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track designation enables the product candidate to become approved and reach the market expeditiously. This may include priority review (i.e., six-month versus the standard ten-month review) and the option to submit a New Drug Application on a rolling basis, enabling FDA to begin reviewing sections of the application before receiving the complete application. According to the FDA, picoplatin is eligible for Fast Track designation due to the unmet medical need -- with no approved therapy for refractory disease, responses seen in two Phase 2 studies, and Poniard's randomized, controlled Phase 3 trial of picoplatin and best supportive care (BSC) versus BSC alone.

About Picoplatin

Picoplatin is a new generation platinum chemotherapy agent. It was designed to overcome platinum resistance and to prolong the time to relapse after chemotherapy in the treatment of solid tumors, and to have an improved safety profile compared with existing platinum-based chemotherapeutics. Poniard received orphan drug designation from the FDA in November 2005 for picoplatin for the treatment of SCLC.

In addition to the SPEAR trial of intravenous picoplatin in SCLC, Poniard is also evaluating intravenous picoplatin in an ongoing Phase 1 clinical trial as a first-line treatment for metastatic colorectal cancer and in an ongoing Phase 2 trial in combination with docetaxel (Taxotere(R)) and prednisone in patients with metastatic hormone-refractory prostate cancer. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors.

About Small Cell
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:

(Date:12/15/2009)... Medical researchers with EDP Biotech Corporation ... new technology for a simple blood test to ... the success of its pre-clinical trials for the ... the biomarker, CA11-19, and all aspects of its ... will detect colon cancer in its earliest, most ...

(Date:12/15/2009)... Dec. 15 Cumberland Pharmaceuticals Inc. ... announced new top-line results for a patient preference ... Solution, a prescription laxative packaged as a crystalline ... ,, Kristalose is the only prescription-strength laxative available ... 50 patients with a recent diagnosis of chronic ...

(Date:12/15/2009)... New York Times article by ... illustrates an internal renal community reimbursement debate that ... deprived of their life-saving immunosuppressive medications beyond the ... is poised to approve this urgent transplant patient ... recipients, behind-the-scenes debate continues within the renal community ...

Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2 Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2 Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3 AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2 Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U S 13803 1 Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U S 13803 2 Bayer Acquires Two Prescription Dermatology Product Lines From SkinMedica in the U S 13803 3 HCA Appoints Dr Richard Tayrien Chief Health Information Officer 56033 1 HCA Appoints Dr Richard Tayrien Chief Health Information Officer 56033 2 Cinergy Health Names Dr Margaret Lewin Chief Medical Director 56029 1 Cinergy Health Names Dr Margaret Lewin Chief Medical Director 56029 2

[0] Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer [0] Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study [0] AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate

... lipids, comprised of triglycerides and cholesterols, vary with genetic ... factors contribute to serum cholesterol and triglyceride levels and ... events. Perhaps no other commonly determined medical laboratory values ... levels of good, bad, and total cholesterol, making the ...

... technology has enabled more and more laboratory testing to ... laboratory is hardly threatened with extinction. National volume data ... ever before, and the huge range of their capabilities, ... volumes of tests assures them an abiding and pivotal ...

Other Medicine Technology:Analyzers Offer Point-of-Care Lipid Panels 2 Analyzers Offer Point-of-Care Lipid Panels 3 When Volume Matters, Immunoassay Systems Deliver 2 When Volume Matters, Immunoassay Systems Deliver 3

Analyzers Offer Point-of-Care Lipid Panels When Volume Matters, Immunoassay Systems Deliver

(Date:12/15/2009)... for protection, CDC says, , , TUESDAY, Dec. 15 (HealthDay ... flu vaccine have been recalled by manufacturer Sanofi Pasteur ... officials said Tuesday. , According to the U.S. Centers ... of the vaccine for children aged 6 months to ... than required potency levels. "This means that doses from ...

(Date:12/15/2009)... BERWYN, Pa., Dec. 15 4R Systems, ... supply chain solutions which help retailers significantly increase ... chain decisions, announced today that The Vitamin Shoppe ... 2008. ,, "4R,s store and DC inventory solutions ... inventory efficiency and in-stocks over the last two ...

(Date:12/15/2009)... BRAINTREE, Mass., Dec. 15 North American ... +3.9% in November year-over-year, according to the ... life insurance applications over the past three months ... 2009 levels of -1.6%, to flat at November,s ... recovering their interest in the benefits available from ...

(Date:12/15/2009)... the past decade, the United Nations Foundation has led ... in the World Malaria Report 2009 that the global strategies for ... for Global Health for the United Nations Foundation , ... ... decade, the United Nations Foundation has led the fight ...

(Date:12/15/2009)... launches SafeConsole 4.0, the web management software for SafeStick, the ... better usability for employees and more control for administrators through ... , ... Washington, DC (PRWEB) December ... of secure USB devices, today launches SafeConsole 4.0, the web ...

Breaking Medicine News(10 mins):Health News:Large Recall of Children's Swine Flu Vaccine 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3 Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4 Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2 Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3 Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2 Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2 Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3

[0] Large Recall of Children's Swine Flu Vaccine [1] 4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance [1] MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November [0] Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 [0] BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices

... Overall medical and pharmacy costs in,people with diabetes ... year in,individuals receiving regular, non-surgical periodontal services, according to,a ... also showed the same,procedures were linked to as much ... further underscore the importance of the link,between medical and ...

... School Portable Guide to Stress Relief, a free guide offered by Harvard ... holidays. , ... Boston (Vocus) December 9, 2008 -- Lately, every day ... economy, rising unemployment. And on top of all that, the holiday season ...

... Foundation for Infectious Diseases, (NFID) Childhood Influenza Immunization ... annual Children,s Flu Vaccination Day (Tuesday, December 9), ... and Prevention,s (CDC) National Influenza Vaccination Week. The ... (FFF) for establishing this day, which emphasizes the ...

... The United Spinal Association ( www.UnitedSpinal.org ) encourages wheelchair and ... call 311 to request a wheelchair-accessible taxi via ... This system links passengers who use wheelchairs with ... NYC can call 311 for a pre-arranged service. 311 connects ...

... will provide Content and Services for Quantros Patient Safety ... PSO Manager Technology Platform , , ... leading provider of safety, quality, and compliance solutions for ... Institute for Safe Medication Practices (ISMP) to provide consultative ...

... Z Trim Holdings, Inc.,(OTC Bulletin Board: ZTMH) issued the following letter ... http://www.newscom.com/cgi-bin/prnh/20081209/AQTU538 ), December 2008, Dear Fellow ... of times; it was the worst of times." You may be,familiar ... Two Cities. , In many ways, ...

University of Michigan, Blue Care Network Study Quantifies Health Care Savings of Regular Dental Care for Patients with Diabetes Free Guide to Remaining Calm During Stressful Times from Harvard Medical School Video: Childhood Influenza Immunization Coalition Supports Second Annual Children's Flu Vaccination Day Accessible Dispatch Program: Accessible Taxi Service for Wheelchair Users in New York City Quantros and ISMP to Partner on PSO Initiatives Z Trim Holdings, Inc. Releases Letter to Shareholders

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Human Papillomavirus (HPV) Low Risk, Paraffin Human Monocytic Ehrlichiosis (HME), HME Antibody IgG Human Immunodeficiency Virus 1, Genotyping Human Immunodeficiency Virus 1 RNA Quantitative PCR with Reflex to Ultrasensitive RNA Quantitative PCR

Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell L...(and obtaining theapprovals required to m...),Health